Related Experiment Videos
[Clinical aspects and therapy of stage III Hodgkin's disease (author's transl)]
Between 1972 and 1974, 50 previously untreated patients with Stage III Hodgkin's disease received medical attention. 24 of them were classified in Stage III A and 26 in Stage III B. In 46 patients the treatment included an initial laparotomy with splenectomy, a 6-month polychemotherapy on the MOPP plan, 4 month's treatment with vinblastine and upper and lower section irradiation. The full remission quota was 84%. After 66 months 78% of all patients were still alive. 62% of the patients are in full remission without relapse, 32% had one recurrence. 10 patients died, 3 of them from Hodgkin's disease and 5 in full remission from infections, septicemia or bone marrow insuffiency.
Between 1972 and 1974, 50 previously untreated patients with Stage III Hodgkin's disease received medical attention. 24 of them were classified in Stage III A and 26 in Stage III B. In 46 patients the treatment included an initial laparotomy with splenectomy, a 6-month polychemotherapy on the MOPP plan, 4 month's treatment with vinblastine and upper and lower section irradiation. The full remission quota was 84%. After 66 months 78% of all patients were still alive. 62% of the patients are in full remission without relapse, 32% had one recurrence. 10 patients died, 3 of them from Hodgkin's disease and 5 in full remission from infections, septicemia or bone marrow insuffiency.